UKGTN Testing Criteria

Size: px
Start display at page:

Download "UKGTN Testing Criteria"

Transcription

1 UKGTN Testing Criteria Approved name and symbol of disease/condition(s): Retinal Degeneration panel test Approved name and symbol of gene(s): a panel of 105 genes, variants of which have been shown to be causative of Retinal Degeneration conditions OMIM number(s): OMIM number(s): Patient name: Patient postcode: Date of birth: NHS number: Name of referrer: Title/Position: Lab ID: Referrals will only be accepted from one of the following: Referrer Consultant Clinical Geneticists Consultant Ophthalmologist with special interest in retinal disorders Tick if this refers to you. Minimum criteria required for testing to be appropriate as stated in the Gene Dossier: Criteria The minimum criteria for acceptance is that the index case: has been diagnosed as a result of symptoms of initial rod dysfunction followed by peripheral cone dysfunction OR a characteristic retinal appearance OR characteristic ERG. X linked RP Autosomal Dominant RP Autosomal Recessive RP Sporadic Tick if this patient meets criteria Additional Information: Please note that if the diagnosis is probable/definite and there is a single gene test for that condition, the clinician may prefer to carry out the single gene test rather than the panel test. For example Retinoschisis (available from Cambridge), Stargardt (available from Oxford), Bardet Biedl (available from Great Ormond Street) and X-linked RP as single test available from Manchester If the sample does not fulfil the clinical criteria or you are not one of the specified types of referrer and you still feel that testing should be performed please contact the laboratory to discuss testing of the sample

2 Appendix 1 Conditions included in the panel Gene HGNC Phenotype Phenotype OMIM # Gene/locus OMIM # CA4 Retinitis pigmentosa 17 # * CERKL Retinitis pigmentosa 26 # * CNGA1 Retinitis pigmentosa 49 # * CNGB1 Retinitis pigmentosa 45 # * CRB1 Leber congenital amaurosis 8 # * Pigmented paravenous chorioretinal atrophy # Retinitis pigmentosa 12, autosomal recessive # CRX Cone rod retinal dystrophy 2 # * Leber congenital amaurosis 7 # EYS Retinitis pigmentosa 25 # * FSCN2 Retinitis pigmentosa 30 # * GUCA1B Retinitis pigmentosa 48 # * IDH3B Retinitis pigmentosa 46 # * IMPDH1 Leber congenital amaurosis 11 # * Retinitis pigmentosa 10 # KLHL7 Retinitis pigmentosa 42 # * MERTK Retinitis pigmentosa 38 # * NR2E3 Enhanced S cone syndrome # * Retinitis pigmentosa 37 # NRL Retinal degeneration, autosomal recessive, clumped pigment type Retinitis pigmentosa 27 # RP1 Retinitis pigmentosa 1 # * RP9 Retinitis pigmentosa 9 # * PDE6A Retinitis pigmentosa 43 # * PDE6B Night blindness, congenital stationary, autosomal # * dominant 2 Retinitis pigmentosa 40 # PRCD Retinitis pigmentosa 36 # * PROM1 Cone rod dystrophy 12 # * Macular dystrophy, retinal, 2 # Retinitis pigmentosa 41 # Stargardt disease 4 # PRPF3 Retinitis pigmentosa 18 # * PRPF31 Retinitis pigmentosa 11 # *606419

3 PRPF8 Retinitis pigmentosa 13 # * PRPH2 Choriodal dystrophy, central areolar 2 # * Foveomacular dystrophy, adult onset, with choroidal # neovascularization Macular dystrophy, patterned # Macular dystrophy, vitelliform # Retinitis pigmentosa 7 # Retinitis pigmentosa, digenic # Retinitis punctata albescens # RGR Retinitis pigmentosa 44 # * RGS9 Bradyopsia # * RHO Night blindness, congenital stationery, autosomal # * dominant 1 Retinitis pigmentosa 4, autosomal dominant or # recessive Retinitis punctata albescens # RLBP1 Bothnia retinal dystrophy # * Fundus albipunctatus # Newfoundland rod cone dystrophy # Retinitis punctata albescens # ROM1 Retinitis pigmentosa 7, digenic # * RP2 Retinitis pigmentosa 2 # * RPE65 Leber congenital amaurosis 2 # * Retinitis pigmentosa 20 # RPGR* Cone rod dystrophy 1 # * Macular degeneration, X linked atrophic # Retinitis pigmentosa 3 # Retinitis pigmentosa, X linked, and sinorespiratory # infections, with or without deafness SAG Oguchi disease 1 # * Retinitis pigmentosa 47 # SEMA4A Cone rod dystrophy 10 # * Retinitis pigmentosa 35 # TOPORS Retinitis pigmentosa 31 # * TTC8 Bardet Biedl syndrome 8 # * Retinitis pigmentosa 51 # TULP1 Leber congenital amaurosis 15 # * Retinitis pigmentosa 14 # CEP290 Bardet Biedl syndrome 14 # * Joubert syndrome 5 # Leber congenital amaurosis 10 # Meckel syndrome type 4 # Senior Loken syndrome 6 #610189

4 AIPL1 Cone rod dystrophy # * Leber congenital amaurosis 4 # Retinitis pigmentosa, juvenile # GUCY2D Cone rod dystrophy 6 # * Leber congenital amaurosis 1 # LCA5 Leber congenital amaurosis 5 # * LRAT Leber congenital amaurosis 14 # * Retinal dystrophy, early onset severe # Retinitis pigmentosa, juvenile # RD3 Leber congenital amaurosis 12 # * RDH12 Leber congenital amaurosis 13 # * SPATA7 Leber congenital amaurosis 3 # * Retinitis pigmentosa, juvenile, autosomal recessive # ADAM9 Cone rod dystrophy 9 # * CACNA2D4 Retinal cone dystrophy 4 # * KCNV2 Retinal cone dystrophy 3B # * RIMS1 Cone rod dystrophy 7 # * RPGRIP1 Cone rod dystrophy 13 # * Leber congenital amaurosis 6 # UNC119 Cone rod dystrophy C1QTNF5 Retinal degeneration, late onset, autosomal dominant # * BEST1 Best macular dystrophy # * Bestrophinopathy # Microcornea, rod cone dystrophy, cataract, and # posterior staphyloma Retinitis pigmentosa, concentric # Retinitis pigmentosa 50 # Vitelliform macular dystrophy, adult onset # Vitreoretinochoroidopathy # ABCA4 Cone rod dystrophy 3 # * Fundus flavimaculatus # Macular degeneration, age related, 2 # Retinal dystrophy, early onset severe # Retinitis pigmentosa 19 # Stargardt disease 1 # CHM Choroideremia # * ELOVL4 Macular dystrophy, autosomal dominant, chromosome # * linked Stargardt disease 3 # CNGA3 Achromatopsia 2 # * CNGB3 Achromatopsia 3 # * Macular degeneration, juvenile # GNAT2 Achromatopsia 4 # * PDE6C Cone dystrophy 4 # * RS1 Retinoschisis # *300839

5 FZD4 Exudative vitreoretinopathy # * Retinopathy of prematurity # LRP5 Exudative vitreoretinopathy 4 # * NDP Exudative vitreoretinopathy, X linked # * Norrie disease # GUCA1A Cone dystrophy 3 # * Cone rod dystrophy 14 # TIMP3 Sorsby fundus dystrophy # * EFEMP1 Doyne honeycomb degeneration of retina # * RDH5 Fundus albipunctatus # * TEAD1 Sveinsson choreoretinal atrophy # * RAX2 Cone rod dystrophy 11 # * Macular degeneration, age related, 6 # CLRN1 Retinitis pigmentosa 61 # * Usher syndrome, type 3A # ARL6 Bardet Biedl syndrome 3 # * Retinitis pigmentosa 55 # BBS1 Bardet Biedl syndrome 1 # * BBS10 Bardet Biedl syndrome 10 # * BBS12 Bardet Biedl syndrome 12 # * BBS2 Bardet Biedl syndrome 2 # * BBS4 Bardet Biedl syndrome 4 # * BBS5 Bardet Biedl syndrome 5 # * BBS7 Bardet Biedl syndrome 7 # * BBS9 Bardet Biedl syndrome 9 # * MKKS Bardet Biedl syndrome 6 # * McKusick Kaufman syndrome # TRIM32 Bardet Biedl syndrome 11 # * DFNB31 Deafness, autosomal recessive 31 # * Usher syndrome, type 2D # GPR98 Usher syndrome, type 2C # * PCDH15 Deafness, autosomal recessive 23 # * Usher syndrome, type 1D/F digenic # Usher syndrome, type 1F # USH2A Retinitis pigmentosa 39 # * Usher syndrome, type 2A # CDH23 Deafness, autosomal recessive 12 # * Usher syndrome, type 1D # Usher syndrome, type 1D/F digenic # MYO7A Deafness, autosomal dominant 11 # * Deafness, autosomal recessive 2 # Usher syndrome, type 1B # USH1C Deafness, autosomal recessive 18 # * Usher syndrome, type 1C # USH1G Usher syndrome, type 1G # * FAM161A Retinitis pigmentosa 28 # *613596

6 C2orf71 Retinitis pigmentosa 54 # * IMPG2 Maculopathy, IMPG2 related # * Retinitis pigmentosa 56 # PDE6G Retinitis pigmentosa 57 # * SNRNP200 Retinitis pigmentosa 33 # * RBP3 Autosomal Recessive Retinitis pigmentosa None given * ZNF513 Retinitis pigmentosa 58 # * CDHR1 Cone rod dystrophy 15 # * RP1L1 Occult macular dystrophy # * OTX2 Microphthalmia, syndromic 5 # * Pituitary hormone deficiency, combined, 6 # Retinal dystrophy, early onset, and pituitary # dysfunction DHDDS Retinitis pigmentosa 59 # * PITPNM3 Cone rod dystrophy 5 # * MKS1 Bardet Biedl syndrome 13 # * Meckel syndrome, type 1 # PRPF6 Retinitis pigmentosa 60 # * UNC119 Cone rod dystrophy

7 Appendix 2 - Genes included in the next generation sequencing assay HGNC Transcript HGNC Transcript HGNC Transcript CA4 NM_ RLBP1 NM_ ELOVL4 NM_ CERKL NM_ ROM1 NM_ CNGA3 NM_ CNGA1 NM_ RP2 NM_ CNGB3 NM_ CNGB1 NM_ RPE65 NM_ GNAT2 NM_ CRB1 NM_ RPGR* NM_ PDE6C NM_ CRX NM_ SAG NM_ RS1 NM_ EYS NM_ SEMA4A NM_ FZD4 NM_ FSCN2 NM_ TOPORS NM_ LRP5 NM_ GUCA1B NM_ TTC8 NM_ NDP NM_ IDH3B NM_ TULP1 NM_ GUCA1A NM_ IDH3B NM_ CEP290 NM_ TIMP3 NM_ IMPDH1 NM_ AIPL1 NM_ EFEMP1 NM_ KLHL7 NM_ GUCY2D NM_ RDH5 NM_ MERTK NM_ LCA5 NM_ TEAD1 NM_ NR2E3 NM_ LRAT NM_ RAX2 NM_ NRL NM_ RD3 NM_ CLRN1 NM_ RP1 NM_ RDH12 NM_ CLRN1 NM_ RP9 NM_ SPATA7 NM_ ARL6 NM_ PDE6A NM_ ADAM9 NM_ BBS1 NM_ PDE6B NM_ CACNA2D4 NM_ BBS10 NM_ PRCD NM_ KCNV2 NM_ BBS12 NM_ PROM1 NM_ RIMS1 NM_ BBS2 NM_ PRPF3 NM_ RIMS1 NM_ BBS4 NM_ PRPF31 NM_ RIMS1 NM_ BBS5 NM_ PRPF8 NM_ RPGRIP1 NM_ BBS7 NM_ PRPH2 NM_ UNC119 NM_ BBS7 NM_ RGR NM_ C1QTNF5 NM_ BBS9 NM_ RGS9 NM_ BEST1 NM_ MKKS NM_ RGS9 NM_ ABCA4 NM_ TRIM32 NM_ RHO NM_ CHM NM_ DFNB31 NM_ GPR98 NM_ CDH23 NM_ IMPG2 NM_ PCDH15 NM_ MYO7A NM_ PDE6G NM_ PCDH15 NM_ USH1C NM_ SNRNP200 NM_ PCDH15 NM_ USH1C NM_ RBP3 NM_ PCDH15 NM_ USH1G NM_ ZNF513 NM_ USH2A NM_ FAM161A NM_ CDHR1 NM_ RP1L1 NM_ PITPNM3 NM_ MKS1 NM_ OTX2 NM_ MKS1 NM_ PRPF6 NM_ DHDDS NM_ Notes: (1) For some genes the analysis of multiple transcripts is required. (2) * For RPGR it is not possible to obtain high quality read for exon ORF15. Consequently this analysis is offered separately on request further details are available at:

8 Appendix 3 - Test strategy Test Criteria Clearly X linked Other referral indication ORF 15 test 105 gene panel test ORF 15 mutation Report No ORF 15 mutation (an additional request is required from referring clinician) Report

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISEASE/CONDITION POPULATION TRIAD Submitting laboratory: 1. Disease/condition approved name and

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Ellingford JM, Sergouniotis PI, Lennon R, et

More information

Variant prioritization

Variant prioritization Variant prioritization University of Cambridge Marta Bleda Latorre Cambridge, UK mb2033@cam.ac.uk 30th September 2014 Research Assistant at the Department of Medicine University of Cambridge Cambridge,

More information

Variant association and prioritization

Variant association and prioritization Variant association and prioritization Edinburgh Genomics Marta Bleda Latorre Edinburgh, UK mb2033@cam.ac.uk 23rd October 2015 Research Assistant at the Department of Medicine University of Cambridge Cambridge,

More information

Phenotype Report. Num. Positions Not Called (Missing data) Num. Variants Assessed

Phenotype Report. Num. Positions Not Called (Missing data) Num. Variants Assessed Report Date: August 19, 2015 Software Annotation Version: 8 Report Name: NA12144 NW European Genome : NA12144_S1 Sequencing Provider: Illumina Sequencing Type: Exome : Retinitis Pigmentosa Description:

More information

Genetic Defect Underlying Progressive Blindness Uncovered by Strand s Clinical Exome Test

Genetic Defect Underlying Progressive Blindness Uncovered by Strand s Clinical Exome Test CASE STUDY Genetic Defect Underlying Progressive Blindness Uncovered by Strand s Clinical Exome Test Patient Profile Swati Koparkar*, a 33-year-old owner of a handicrafts boutique had been experiencing

More information

Address City State Zip Phone. the hospital/facility:

Address City State Zip Phone. the hospital/facility: PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:

More information

Retinal dystrophies, genomic applications in diagnosis and prospects for therapy

Retinal dystrophies, genomic applications in diagnosis and prospects for therapy Review Article Retinal dystrophies, genomic applications in diagnosis and prospects for therapy Benjamin M. Nash 1,2,3, Dale C. Wright 2,3, John R. Grigg 1, Bruce Bennetts 2,3, Robyn V. Jamieson 1,3 1

More information

Comprehensive genetic testing for hearing and vision loss

Comprehensive genetic testing for hearing and vision loss Comprehensive genetic testing for hearing and vision loss Hearing and vision loss can result from both genetic and non-genetic etiologies In general, there is a genetic basis for up to 50% of prelingual

More information

Genetics and the Macular Dystrophies. George Anadiotis D.O. Medical Director Clinical and Biochemical Genetics Randall Children s Hospital

Genetics and the Macular Dystrophies. George Anadiotis D.O. Medical Director Clinical and Biochemical Genetics Randall Children s Hospital Genetics and the Macular Dystrophies George Anadiotis D.O. Medical Director Clinical and Biochemical Genetics Randall Children s Hospital Stargardt disease Best Vitelliform Macular Dystrophy North Carolina

More information

RetNet panel. Microcornea, myopic chorioretinal atrophy, and telecanthus, (3), Autosomal recessive ADGRA No OMIM phenotype

RetNet panel. Microcornea, myopic chorioretinal atrophy, and telecanthus, (3), Autosomal recessive ADGRA No OMIM phenotype versie 27-Feb-2018 (266 genen) RetNet panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern ABCA4 601691 Cone-rod

More information

한국인망막색소변성증환자에서발견한복합이형접합 EYS 변이 1 예보고

한국인망막색소변성증환자에서발견한복합이형접합 EYS 변이 1 예보고 편지 Lab Med Online Vol. 8, No. 2: 66-70, April 2018 진단유전학 한국인망막색소변성증환자에서발견한복합이형접합 EYS 변이 1 예보고 Identification of Compound Heterozygous EYS Variants in a Korean Patient with Retinitis Pigmentosa 김형태 1 장자현

More information

GENE THERAPY FOR INHERITED RETINAL DISEASE

GENE THERAPY FOR INHERITED RETINAL DISEASE Release Date: July 1, 2018 Expiration Date: July 31, 2019 Last Review: May 25, 2018 July 2018 A CME-Accredited Activity Brave New World: GENE THERAPY FOR INHERITED RETINAL DISEASE Distinguished Faculty

More information

Next generation sequencing identified novel heterozygous nonsense mutation in CNGB1 gene associated with retinitis pigmentosa in a Chinese patient

Next generation sequencing identified novel heterozygous nonsense mutation in CNGB1 gene associated with retinitis pigmentosa in a Chinese patient /, 2017, Vol. 8, (No.51), pp: 88345-88350 Next generation sequencing identified novel heterozygous nonsense mutation in CNGB1 gene associated with retinitis pigmentosa in a Chinese patient Santasree Banerjee

More information

Genes and mutations causing retinitis pigmentosa

Genes and mutations causing retinitis pigmentosa Clin Genet 013: 84: 13 141 Printed in Singapore. All rights reserved Review 013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.103 Genes and mutations causing

More information

CilioPathy panel. 3-Jul-2018 (102 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID

CilioPathy panel. 3-Jul-2018 (102 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID versie 3-Jul-2018 (102 genen) CilioPathy panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern AHI1 608894 Joubert

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Leber congenital amaurosis OMIM number for disease 204000 Disease alternative

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Choroideremia OMIM number for disease 303100 Disease alternative names please

More information

Unravelling the genetic basis of simplex Retinitis Pigmentosa cases

Unravelling the genetic basis of simplex Retinitis Pigmentosa cases SUPPLEMENTARY INFORMATION Unravelling the genetic basis simplex Retinitis Pigmentosa cases Nereida Bravo-Gil 1,2#, María González-del Pozo 1,2#, Marta Martín-Sánchez 1, Cristina Méndez-Vidal 1,2, Enrique

More information

Symptoms, causes and treatment options of different IRDs

Symptoms, causes and treatment options of different IRDs Symptoms, causes and treatment options of different IRDs While all IRDs affect the retina and visual function, the symptoms, onset, progression and cause of each varies. Here, we will give an overview

More information

Exceptional progress has been made during the past two decades in identifying genes

Exceptional progress has been made during the past two decades in identifying genes SPECIAL ARTICLE Perspective on Genes and Mutations Causing Retinitis Pigmentosa Stephen P. Daiger, PhD; Sara J. Bowne, PhD; Lori S. Sullivan, PhD Exceptional progress has been made during the past two

More information

Cone-Rod Degeneration with Sensorineural Hearing Loss

Cone-Rod Degeneration with Sensorineural Hearing Loss The American Journal of Human Genetics, Volume 99 Supplemental Data Bi-allelic Truncating Mutations in CEP78, Encoding Centrosomal Protein 78, Cause Cone-Rod Degeneration with Sensorineural Hearing Loss

More information

Cleveland Clinic Laboratories

Cleveland Clinic Laboratories Cleveland Clinic Laboratories Technical Update July 2015 Cleveland Clinic Laboratories is dedicated to keeping you updated and informed about recent testing changes. That s why we are happy to provide

More information

Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies

Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies Review series Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies Anneke I. den Hollander, 1,2 Aaron Black, 3 Jean Bennett, 3 and Frans P.M. Cremers 2,4

More information

Recent Advances in Genetics of Retinal Dystrophies and Gene Therapy. Anita Agarwal, MD West Coast Retina San Francisco, CA

Recent Advances in Genetics of Retinal Dystrophies and Gene Therapy. Anita Agarwal, MD West Coast Retina San Francisco, CA Recent Advances in Genetics of Retinal Dystrophies and Gene Therapy Anita Agarwal, MD West Coast Retina San Francisco, CA None Disclosures Retinal Dystrophies Able to identify the disease causing gene(s)

More information

Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome

Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome Retina Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome Lynn W. Sun, 1 Ryan D. Johnson, 1 Christopher S. Langlo, 2 Robert F. Cooper, 3 Moataz M. Razeen, 1,4 Madia C. Russillo,

More information

Gene therapy for Inherited Retinal Diseases MD(Res) Thesis by Venki Sundaram

Gene therapy for Inherited Retinal Diseases MD(Res) Thesis by Venki Sundaram Gene therapy for Inherited Retinal Diseases MD(Res) Thesis by Venki Sundaram Division of Molecular Therapy Institute of Ophthalmology University College London Abstract Inherited retinal diseases include

More information

INHERITED RETINAL DISEASE. The Rod/Cone Dichotomy. Case History/Entrance Skills. Health Assessment 9/4/18. Hereditary Retinal Diseases Epidemiology

INHERITED RETINAL DISEASE. The Rod/Cone Dichotomy. Case History/Entrance Skills. Health Assessment 9/4/18. Hereditary Retinal Diseases Epidemiology Hereditary Retinal Diseases Epidemiology INHERITED RETINAL DISEASE Blair Lonsberry, MS, OD, MEd., FAAO Professor of Optometry Pacific University College of Optometry blonsberry@pacificu.edu HRDs affect

More information

Retinitis Pigmentosa: A Brief Review of the Genetic and Clinical Aspects of the Disease. Itia Dowdell

Retinitis Pigmentosa: A Brief Review of the Genetic and Clinical Aspects of the Disease. Itia Dowdell Retinitis Pigmentosa: A Brief Review of the Genetic and Clinical Aspects of the Disease Itia Dowdell Science and Technology Honors Program, University of Alabama at Birmingham, Birmingham, AL, USA School

More information

INDEX. Genetics. French poodle progressive rod-cone degeneration,

INDEX. Genetics. French poodle progressive rod-cone degeneration, INDEX Acuity in Stargardt's macular dystrophy, 25-34 ADRP (Autosomal dominant retinitis pigmentosa), see Retinitis pigmentosa and Genetics afgf, 294, 296 Age-related maculopathy, see Macular degeneration

More information

QLT Inc Rationale and Background for the development of QLT (Note: QLT is not approved for commercial use in any countries, worldwide)

QLT Inc Rationale and Background for the development of QLT (Note: QLT is not approved for commercial use in any countries, worldwide) QLT Inc Rationale and Background for the development of QLT091001 (Note: QLT091001 is not approved for commercial use in any countries, worldwide) Introduction QLT Inc. (QLT) is a Canadian company focused

More information

The current status of molecular diagnosis of inherited retinal dystrophies

The current status of molecular diagnosis of inherited retinal dystrophies REVIEW C URRENT OPINION The current status of molecular diagnosis of inherited retinal dystrophies John (Pei-wen) Chiang a and Karmen Trzupek b Purpose of review We are witnessing lightning-fast advances

More information

Applying structure-function to solve clinical cases

Applying structure-function to solve clinical cases Applying structure-function to solve clinical cases Professor Michael Kalloniatis Centre for Eye Health, and, School of Optometry and Vision Science Acknowledgements Some material prepared by Nayuta Yoshioka

More information

Retinitis pigmentosa and allied conditions today: a paradigm of translational research

Retinitis pigmentosa and allied conditions today: a paradigm of translational research REVIEW Retinitis pigmentosa and allied conditions today: a padigm of translational resech Cmen Ayuso* 1 and Jose M Millan 2 Abstract Monogenic human retinal dystrophies e a group of disorders chacterized

More information

Utilization of the MiSeq in a clinical lab. Tony Krentz, PhD PreventionGenetics

Utilization of the MiSeq in a clinical lab. Tony Krentz, PhD PreventionGenetics Utilization of the MiSeq in a clinical lab Tony Krentz, PhD PreventionGenetics PreventionGenetics Founded in 2004 in Marshfield, Wisconsin by James Weber ~90 employees Largest test menu in US Vision: Disease

More information

RPE65-associated Leber Congenital Amaurosis

RPE65-associated Leber Congenital Amaurosis RPE65-associated Leber Congenital Amaurosis Brian Privett, MD, Edwin M. Stone, MD, PhD February 16, 2010 Chief Complaint: Poor fixation at 4 months of age History of Present Illness: This 7 year old female

More information

Investigation of the genetic cause and related phenotypes of rare early onset retinal dystrophies

Investigation of the genetic cause and related phenotypes of rare early onset retinal dystrophies Investigation of the genetic cause and related phenotypes of rare early onset retinal dystrophies Sarah Hull Institute of Ophthalmology, University College London Submitted to the University College London

More information

Whole exome sequencing Gene package Vision disorders version 3,

Whole exome sequencing Gene package Vision disorders version 3, Whole Exome Sequencing Gene package Vision disorders, version 3, 1 7 2017 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on

More information

Heterotaxie PCD (Primaire ciliaire dyskinesie) panel

Heterotaxie PCD (Primaire ciliaire dyskinesie) panel Heterotaxie PCD (Primaire ciliaire dyskinesie) panel versie V1 (92 genen) Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/105786

More information

Whole exome sequencing Gene package Vision disorders version 5,

Whole exome sequencing Gene package Vision disorders version 5, Whole Exome Sequencing Gene package Vision disorders, version 5, 30 7 2018 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced on

More information

Research Article Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations

Research Article Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal Dystrophy in Japanese Populations Journal of Ophthalmology Volume 2015, Article ID 819760, 10 pages http://dx.doi.org/10.1155/2015/819760 Research Article Retinitis Pigmentosa with EYS Mutations Is the Most Prevalent Inherited Retinal

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing

More information

RETINITIS PIGMENTOSA A RARE GENETICAL DISORDER

RETINITIS PIGMENTOSA A RARE GENETICAL DISORDER RETINITIS PIGMENTOSA A RARE GENETICAL DISORDER Retinitis pigmentosa (RP) is a group of inherited disorders affecting 1 in 3000-7000 people and characterized by abnormalities of the photoreceptors (rods

More information

Top Pediatric Retinal Diseases you don t want to miss! Retinopathy of Prematurity (ROP) Aggressive, Posterior ROP (AP ROP)

Top Pediatric Retinal Diseases you don t want to miss! Retinopathy of Prematurity (ROP) Aggressive, Posterior ROP (AP ROP) Top 10 10 Pediatric Retinal Diseases you don t want to miss! Polly Quiram MD, PhD Vitreoretinal Surgery, PA Retinal Update Jan 26th, 2018 ROP Retinoblastoma Coats disease Persistent fetal vasculature Familial

More information

Usher Syndrome: When to Suspect it and How to Find It

Usher Syndrome: When to Suspect it and How to Find It Usher Syndrome: When to Suspect it and How to Find It Margaret Kenna, MD, MPH Katherine Lafferty, MS, CGC Heidi Rehm, PhD Anne Fulton, MD Harvard Medical School Harvard Medical School Center for Hereditary

More information

Cataract and optic disk drusen in a patient with glycogenosis and di George syndrome: clinical and molecular report

Cataract and optic disk drusen in a patient with glycogenosis and di George syndrome: clinical and molecular report Allegrini et al. BMC Ophthalmology (2017) 17:107 DOI 10.1186/s12886-017-0499-y CASE REPORT Cataract and optic disk drusen in a patient with glycogenosis and di George syndrome: clinical and molecular report

More information

Grand Rounds. November 20, SUNY Downstate Medical Center Department of Ophthalmology. ~Boleslav Kotlyar, MD~

Grand Rounds. November 20, SUNY Downstate Medical Center Department of Ophthalmology. ~Boleslav Kotlyar, MD~ Grand Rounds November 20, 2014 SUNY Downstate Medical Center Department of Ophthalmology ~Boleslav Kotlyar, MD~ Subjective HPI: 28 yo Hispanic F presents for initial eval, c/o gradually worsening vision

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name OMIM number for disease 231300 Disease alternative names Please provide any alternative

More information

The Molecular Basis of Retinal Dystrophies in Pakistan

The Molecular Basis of Retinal Dystrophies in Pakistan Genes 2014, 5, 176-195; doi:10.3390/genes5010176 Review OPEN ACCESS genes ISSN 2073-4425 www.mdpi.com/journal/genes The Molecular Basis of Retinal Dystrophies in Pakistan Muhammad Imran Khan 1,2,, Maleeha

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing

More information

The Genetics of Usher Syndrome

The Genetics of Usher Syndrome The Genetics of Usher Syndrome Heidi L. Rehm, PhD, FACMG Assistant Professor of Pathology, BWH and HMS Director, Laboratory for Molecular Medicine, PCPGM DNA is Highly Compacted into Chromosomes The DNA

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Genetic Causes of Hypothyroidism 1. Loss of function mutations in TSHR cause thyroid

More information

cataract panel 16-Apr-2018 (63 genen) Centrum voor Medische Genetica Gent versie OMIM gene ID

cataract panel 16-Apr-2018 (63 genen) Centrum voor Medische Genetica Gent versie OMIM gene ID versie 16-Apr-2018 (63 genen) cataract panel Centrum voor Medische Genetica Gent Gene OMIM gene ID AGK 610345 ALDH18A1 138250 Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Amyotrophic Lateral Sclerosis 10 (ALS10) and Amyotrophic Lateral Sclerosis 6 (ALS6)

More information

Insight into Leber congenital amaurosis: potential for gene therapy

Insight into Leber congenital amaurosis: potential for gene therapy For reprint orders, please contact reprints@expert-reviews.com Insight into Leber congenital amaurosis: potential for gene therapy Expert Rev. Ophthalmol. 6(2), 203 209 (2011) Dania Qatarneh 1, Hemal Mehta

More information

CLINICAL SCIENCES. Molecular Testing for Hereditary Retinal Disease as Part of Clinical Care

CLINICAL SCIENCES. Molecular Testing for Hereditary Retinal Disease as Part of Clinical Care CLINICAL SCIENCES Molecular Testing for Hereditary Retinal Disease as Part of Clinical Care Katy Downs, MS; David N. Zacks, MD, PhD; Rafael Caruso, MD; Athanasios J. Karoukis, BS; Kari Branham, MS; Beverly

More information

Clinico-Pathological Atlas of Congenital Fundus Disorders

Clinico-Pathological Atlas of Congenital Fundus Disorders Clinico-Pathological Atlas of Congenital Fundus Disorders Juan Orellana Alan H. Friedman Clinico-Pathological Atlas of Congenital Fundus Disorders With 236 Illustrations 196 in Color Springer Science+

More information

Molecular Diagnostic Testing by eyegene: Analysis of Patients With Hereditary Retinal Dystrophy Phenotypes Involving Central Vision Loss

Molecular Diagnostic Testing by eyegene: Analysis of Patients With Hereditary Retinal Dystrophy Phenotypes Involving Central Vision Loss Genetics Molecular Diagnostic Testing by eyegene: Analysis of Patients With Hereditary Retinal Dystrophy Phenotypes Involving Central Vision Loss Akhila Alapati, 1 Kerry Goetz, 2 John Suk, 1 Mili Navani,

More information

11/14/2013. Progressive Eye Conditions. Agenda. Review from Sessions 1 and 2 Session 1 Review of Eye Conditions. Objectives

11/14/2013. Progressive Eye Conditions. Agenda. Review from Sessions 1 and 2 Session 1 Review of Eye Conditions. Objectives 1 Progressive Eye Conditions Agenda 2:00 Introductions and Reconnect FIMC-VI Webinar Series Eye Conditions and Impact on Learning Session #3 of 3 November 13, 2013 Kay Ratzlaff Florida Instructional Materials

More information

REVIEW. Advances in Gene Therapy for Diseases of the Eye. j 563. Lolita Petit, 1 Hemant Khanna, 1,2 and Claudio Punzo 1,2, * INTRODUCTION

REVIEW. Advances in Gene Therapy for Diseases of the Eye. j 563. Lolita Petit, 1 Hemant Khanna, 1,2 and Claudio Punzo 1,2, * INTRODUCTION REVIEW Advances in Gene Therapy for Diseases of the Eye Lolita Petit, 1 Hemant Khanna, 1,2 and Claudio Punzo 1,2, * 1 Department of Ophthalmology and Gene Therapy Center, and 2 Department of Neurobiology,

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Voretigene Neparvovec-rzyl (Luxturna) File Name: Origination: Last CAP Review: Next CAP Review: Last Review: voretigene_neparvovec_rzyl_luxturna 1/2018 N/A 6/2018 2/2018 Description

More information

Anthony G. Robson Æ Michel Michaelides Æ Zubin Saihan Æ Alan C. Bird Æ Andrew R. Webster Æ Anthony T. Moore Æ Fred W. Fitzke Æ Graham E.

Anthony G. Robson Æ Michel Michaelides Æ Zubin Saihan Æ Alan C. Bird Æ Andrew R. Webster Æ Anthony T. Moore Æ Fred W. Fitzke Æ Graham E. Doc Ophthalmol (2008) 116:79 89 DOI 10.1007/s10633-007-9087-4 ORIGINAL RESEARCH ARTICLE Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density

More information

Advances in assessing and managing vision impairment

Advances in assessing and managing vision impairment Advances in assessing and managing vision impairment John Grigg Associate Professor and Head Discipline of Ophthalmology Consultant Ophthalmologist Sydney Eye Hospital and The Children s Hospital at Westmead

More information

FOUNDATION OVERVIEW. Over the past four decades, the Foundation has raised $600 million to put an end to retinal degenerative diseases.

FOUNDATION OVERVIEW. Over the past four decades, the Foundation has raised $600 million to put an end to retinal degenerative diseases. FOUNDATION OVERVIEW Passion and Focus The Foundation Fighting Blindness was established in 1971 by a passionate group of individuals driven to overcome blinding eye diseases that were affecting themselves

More information

Year 4 Results For a Phase 1 Trial of Voretigene Neparvovec in Biallelic RPE65- Mediated Inherited Retinal Disease

Year 4 Results For a Phase 1 Trial of Voretigene Neparvovec in Biallelic RPE65- Mediated Inherited Retinal Disease 8:00 AM Year 4 Results For a Phase 1 Trial of Voretigene Neparvovec in Biallelic RPE65- Mediated Inherited Retinal Disease Albert M. Maguire, MD OBJECTIVE Assess maintenance of functional vision/visual

More information

Usher syndrome Close to a cure? The Path to Clinical Trials

Usher syndrome Close to a cure? The Path to Clinical Trials Usher syndrome Close to a cure? The Path to Clinical Trials William J. Kimberling, PhD Boys Town Hospital, Omaha NE and and Institute for Vision Research Collaborative Center for Deaf-Blind Studies University

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our

More information

LUXTURNA (voretigene neparovec-rzyl)

LUXTURNA (voretigene neparovec-rzyl) LUXTURNA (voretigene neparovec-rzyl) Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical

More information

Genetics and Genomics: Applications to Developmental Disability

Genetics and Genomics: Applications to Developmental Disability Tuesday, 12:30 2:00, B1 Objective: Genetics and Genomics: Applications to Developmental Disability Helga Toriello 616-234-2712 toriello@msu.edu Identify advances in clinical assessment and management of

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) (A)-Testing

More information

Usher syndrome Close to a cure? The Path to Clinical Trials

Usher syndrome Close to a cure? The Path to Clinical Trials Usher syndrome Close to a cure? The Path to Clinical Trials William J. Kimberling, PhD Boys Town Hospital, Omaha NE and and Institute for Vision Research Collaborative Center for Deaf-Blind Studies University

More information

Diseases Caused by Defects in the Visual Cycle: Retinoids as Potential Therapeutic Agents

Diseases Caused by Defects in the Visual Cycle: Retinoids as Potential Therapeutic Agents Annu. Rev. Pharmacol. Toxicol. 2007. 47:469 512 First published online as a Review in Advance on September 12, 2006 The Annual Review of Pharmacology and Toxicology is online at http://pharmtox.annualreviews.org

More information

Visual Conditions in Infants and Toddlers

Visual Conditions in Infants and Toddlers Visual Conditions and Functional Vision: Early Intervention Issues Visual Conditions in Infants and Toddlers Brief Overview of Childhood Visual Disorders Hatton, D.D. (2003). Brief overview of childhood

More information

A detailed study of the phenotype of an autosomal dominant cone-rod dystrophy (CORD7) associated with mutation in the gene for RIM1

A detailed study of the phenotype of an autosomal dominant cone-rod dystrophy (CORD7) associated with mutation in the gene for RIM1 198 EXTENDED REPORT A detailed study of the phenotype of an autosomal dominant cone-rod dystrophy (CORD7) associated with mutation in the gene for RIM1 M Michaelides, G E Holder, D M Hunt, F W Fitzke,

More information

The effect of intravitreal bevacizumab in a rare case of retinal dystrophy with secondary cystoid macular edema

The effect of intravitreal bevacizumab in a rare case of retinal dystrophy with secondary cystoid macular edema Romanian Journal of Ophthalmology, Volume 61, Issue 2, April-June 2017. pp:123-127 CASE REPORT The effect of intravitreal bevacizumab in a rare case of retinal dystrophy with secondary cystoid macular

More information

Achromatopsia NGS 6 ATF6, CNGA3, CNGB3, GNAT2, PDE6C, PDE6H ARMS2, CFH Sequencing PAX6

Achromatopsia NGS 6 ATF6, CNGA3, CNGB3, GNAT2, PDE6C, PDE6H ARMS2, CFH Sequencing PAX6 Disease/Condition name Method No of Asper Ophthalmics Achromatopsia 6 ATF6, CNGA3, CNGB3, GNAT2, PDE6C, PDE6H 05 Age-related Macular Degeneration 2 ABCA4, ARMS2, C2, C3, C9, CCR3, CFB, CFH, 995* CFI, CST3,

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Parkinson disease 8, automsomal dominant OMIM number for disease 607060 Disease

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name OMIM number for disease 147920 Disease alternative names Please provide any alternative

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name HEMOCHROMATOSIS, TYPE 4; HFE4 OMIM number for disease #606069 Disease alternative

More information

MAC-ASD panel. 16-Apr-2018 (59 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID

MAC-ASD panel. 16-Apr-2018 (59 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID versie 16-Apr-2018 (59 genen) MAC-ASD panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern ABCB6 605452 [Blood

More information

Update In Management Of Heriditary Retinal Degenerations

Update In Management Of Heriditary Retinal Degenerations Update In Management Of Heriditary Retinal Degenerations Dr. Manju Lalwani The retina is lined with a layer of light -sensitive cells consisting of rods and cones. The rods function in conditions of low

More information

MOLECULAR GENETICS OF HUMAN RETINAL DISEASE

MOLECULAR GENETICS OF HUMAN RETINAL DISEASE ?Annu. Rev. Genet. 1999. 33:89 131 Copyright c 1999 by Annual Reviews. All rights reserved Amir Rattner, 1,4 Hui Sun, 1,4 and Jeremy Nathans 1 4 1 Department of Molecular Biology and Genetics, 2 Department

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Epileptic encephalopathy, early infantile 4. OMIM number for disease 612164 Disease

More information

Detection of Variants in 15 Genes in 87 Unrelated Chinese Patients with Leber Congenital Amaurosis

Detection of Variants in 15 Genes in 87 Unrelated Chinese Patients with Leber Congenital Amaurosis Detection of Variants in 15 Genes in 87 Unrelated Chinese Patients with Leber Congenital Amaurosis Lin Li 1,2, Xueshan Xiao 1, Shiqiang Li 1, Xiaoyun Jia 1, Panfeng Wang 1, Xiangming Guo 1, Xiaodong Jiao

More information

Submitting Laboratory: London NE RGC GOSH

Submitting Laboratory: London NE RGC GOSH Submitting laboratory: London NE RGC GOSH 1. Disorder/condition approved name (please provide UK spelling if different from US) and symbol as published on the OMIM database (alternative names will be listed

More information

A Practical Approach to Pediatric Retinal Diseases

A Practical Approach to Pediatric Retinal Diseases A Practical Approach to Pediatric Retinal Diseases Diana Shechtman OD FAAO Consultative Optometric Physician RMSM Adjunct Professor, Nova Southeastern University Rachel Stacey Coulter OD MS FAAO Professor,

More information

How the eye works. Causes of retinitis pigmentosa

How the eye works. Causes of retinitis pigmentosa Retinitis pigmentosa Retinitis pigmentosa (RP) is the name given to a diverse group of inherited eye disorders which affect a part of the eye called the retina. RP causes permanent changes to your vision

More information

Course C21. Visual Electrophysiology in Children. 12 June, :15-17:45 hrs. Room 118/119 HAND-OUTS

Course C21. Visual Electrophysiology in Children. 12 June, :15-17:45 hrs. Room 118/119 HAND-OUTS Course C21 Visual Electrophysiology in Children 12 June, 2017 16:15-17:45 hrs Room 118/119 HAND-OUTS Introducing visual electrophysiology tests and results Ruth Hamilton - A description of paeditaric tests

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISORDER/CONDITION POPULATION TRIAD Submitting laboratory: Exeter RGC Approved: Sept 2013 1. Disorder/condition

More information

Patient AB. Born in 1961 PED

Patient AB. Born in 1961 PED Clinical Atlas Patient AB Born in 1961 PED Autofluorescence Dilated 45 EasyScan Zero-dilation IR 45 Fundus Dilated 45 In the fundus photos (Canon CX1) the PED is not able to be seen. However, the extent

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names you wish listed) Glucocorticoid-remediable

More information

Since the mapping of the first locus for autosomal

Since the mapping of the first locus for autosomal Genetic Modifiers and Oligogenic Inheritance Maria Kousi and Nicholas Katsanis Center for Human Disease Modeling, Duke University, Durham, North Carolina 27710 Correspondence: katsanis@cellbio.duke.edu

More information

Retinal Dehydrogenase 12 (RDH12) Mutations in Leber Congenital Amaurosis

Retinal Dehydrogenase 12 (RDH12) Mutations in Leber Congenital Amaurosis Am. J. Hum. Genet. 75:639 646, 2004 Retinal Dehydrogenase 12 (RDH12) Mutations in Leber Congenital Amaurosis Isabelle Perrault, 1 Sylvain Hanein, 1 Sylvie Gerber, 1 Fabienne Barbet, 1 Dominique Ducroq,

More information

Two heterozygous mutations identified in one Chinese patient with bilateral macular coloboma

Two heterozygous mutations identified in one Chinese patient with bilateral macular coloboma MOLECULAR MEDICINE REPORTS 16: 2505-2510, 2017 Two heterozygous mutations identified in one Chinese patient with bilateral macular coloboma TAO LI 1*, YING LIN 1*, HONGBIN GAO 2,3, CHUAN CHEN 1,4, YI ZHU

More information

Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy

Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy Additional material is published online only. To view please visit the journal online (http:// dx. doi. org/ 10. 1136/ bjophthalmol- 2018-313278). 1 UCL Institute of Ophthalmology, University College London,

More information

1.! Yes I do. 2.! No I don t. COPE Approved: COPE # PD! " !! What is electrodiagnostics testing? !! Visual Pathway Basic Understanding !!

1.! Yes I do. 2.! No I don t. COPE Approved: COPE # PD!  !! What is electrodiagnostics testing? !! Visual Pathway Basic Understanding !! 1.! Yes I do 2.! No I don t Nathan Lighthizer, O.D., F.A.A.O Assistant Professor, NSUOCO Chief of Specialty Care Clinics Chief of Electrodiagnostics Clinic COPE Approved: COPE # 3132-PD #$ #$! " 1.! Monthly

More information

Autosomal Dominant Retinal Dystrophies Caused by a Founder Splice Site Mutation, c.828+3a>t, in PRPH2 and Protein Haplotypes in trans as Modifiers

Autosomal Dominant Retinal Dystrophies Caused by a Founder Splice Site Mutation, c.828+3a>t, in PRPH2 and Protein Haplotypes in trans as Modifiers Autosomal Dominant Retinal Dystrophies Caused by a Founder Splice Site Mutation, c.828+3a>t, in PRPH2 and Protein Haplotypes in trans as Modifiers Suma Shankar, Emory University Dianna K. Hughbanks-Wheaton,

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name and description (please provide any alternative names Osteogenesis Imperfecta

More information